Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Endocrine reviews

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EDRV.18.6.0318PMID 9408743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone Inhibits Progesterone Production in Porcine Granulosa Cells *

  1998cited by this paper
• Mechanisms of anovulation in polycystic ovary syndrome

  1997cited by this paper
• Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

  1997cited by this paper
• Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

  1997cited by this paper
• Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity.

  1997cited by this paper
• Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization

  1997cited by this paper
• Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome *

  1997cited by this paper
• Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.

  1997cited by this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cited by this paper
• Genetic Analysis of NIDDM: The Study of Quantitative Traits

  1996cited by this paper
• Leptin: The Tale of an Obesity Gene

  1996cited by this paper
• A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2

  1996cited by this paper
• Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome.

  1996cited by this paper
• IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

  1996cited by this paper
• Mitochondria and Diabetes: Genetic, Biochemical, and Clinical Implications of the Cellular Energy Circuit

  1996cited by this paper
• Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.

  1996cited by this paper
• Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome.

  1996cited by this paper
• Altered fibrinolysis and platelet function in the development of vascular complications of diabetes

  1996cited by this paper
• Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.

  1996cited by this paper
• Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

  1996cited by this paper
• The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

  1996influential reference
• The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

  1996cited by this paper
• Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndrome

  1996influential reference
• Cellular and Molecular Mechanisms of Non-Insulin Dependent Diabetes Mellitus

  1996influential reference
• Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

  1996cited by this paper
• Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries.

  1996cited by this paper
• Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

  1996influential reference
• Can metformin reduce insulin resistance in polycystic ovary syndrome?

  1996cited by this paper
• Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

  1996influential reference
• NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.

  1996cited by this paper
• Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.

  1996cited by this paper
• 5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries.

  1996cited by this paper
• Androgens in men--uses and abuses.

  1996cited by this paper
• Hyperinsulinemia is common in family members of women with polycystic ovary syndrome.

  1996cited by this paper
• Mechanisms Behind Insulin Resistance in Rat Skeletal Muscle After Oophorectomy and Additional Testosterone Treatment

  1996cited by this paper
• Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.

  1996cited by this paper
• Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

  1995influential reference
• Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor.

  1995cited by this paper
• Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.

  1995cited by this paper
• Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes

  1995cited by this paper
• Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

  1995influential reference
• The burden of osteoporosis: cost.

  1995cited by this paper
• A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

  1995influential reference
• 3 The Genetics of Non-insulin-Dependent Diabetes Mellitus

  1995cited by this paper
• Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.

  1995cited by this paper
• Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome.

  1995cited by this paper
• Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

  1995cited by this paper
• Gender and Insulin Sensitivity in the Heart and in Skeletal Muscles: Studies Using Positron Emission Tomography

  1995cited by this paper
• 4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*)

  1995cited by this paper
• Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

  1995cited by this paper
• Coronary heart disease risk factors in women with polycystic ovary syndrome.

  1995cited by this paper
• Role of IRS-2 in insulin and cytokine signalling

  1995cited by this paper
• A twin study of polycystic ovary syndrome.

  1995cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1995cited by this paper
• Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.

  1995cited by this paper
• Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

  1995cited by this paper
• Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications

  1995cited by this paper
• The role of dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis.

  1995cited by this paper
• Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Quantitative and selective fluorophore labeling of phosphoserine on peptides and proteins: characterization at the attomole level by capillary electrophoresis and laser-induced fluorescence.

  1995cited by this paper
• The genetics of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

  1995cited by this paper
• Polycystic ovary syndrome.

  1995influential reference
• Molecular and cellular aspects of the insulin-like growth factor I receptor.

  1995cited by this paper
• The genetics of polycystic ovary syndrome.

  1995cited by this paper
• Insulin action and the insulin signaling network.

  1995influential reference
• Polycystic ovary disease. A risk factor for gestational diabetes?

  1995cited by this paper
• Obesity, lipids, cardiovascular risk, and androgen excess.

  1995cited by this paper
• Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.

  1995cited by this paper
• Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

  1995cited by this paper
• Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans.

  1995cited by this paper
• Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1.

  1994cited by this paper
• Insulin Action, Diabetogenes, and the Cause of Type II Diabetes

  1994cited by this paper
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

  1994cited by this paper
• Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

  1994cited by this paper
• Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

  1994cited by this paper
• Genetic dissection of complex traits.

  1994cited by this paper
• Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics

  1994cited by this paper
• The IRS-1 signaling system.

  1994cited by this paper
• Evaluation of WHO and NDDG criteria for impaired glucose tolerance.

  1994cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper
• Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

  1994cited by this paper
• Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.

  1994cited by this paper
• Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

  1994cited by this paper
• Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.

  1994cited by this paper
• Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.

  1994cited by this paper
• Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome.

  1994cited by this paper
• Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.

  1994cited by this paper
• Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

  1994cited by this paper
• Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.

  1994cited by this paper
• Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome.

  1994cited by this paper
• A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).

  1994cited by this paper
• Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor.

  1994cited by this paper
• Induction of insulin resistance by androgens and estrogens.

  1994influential reference
• Phosphorylation of 17 beta-hydroxysteroid dehydrogenase in BeWo choriocarcinoma cells.

  1994cited by this paper

• Relationship between hypothalamic-pituitary-adrenal axis activity and menstrual irregularities in women with polycystic ovary syndrome.

  2026cites this paper
• The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome

  2026cites this paper
• Manejo integral del síndrome de ovario poliquístico: revisión sistemática de estrategias terapéuticas farmacológicas

  2026cites this paper
• Herbal Pathways to Hormonal Balance: A Comprehensive Review on Natural Treatments for Polycystic Ovary Syndrome (PCOS)

  2026cites this paper
• Unmet clinical needs in women with polycystic ovary syndrome regarding chronic non-communicable diseases: A cross‑sectional study

  2026cites this paper
• Effects of fenugreek seed extract on luteinizing and follicle-stimulating hormones in women with polycystic ovary syndrome: a randomized controlled trial

  2026cites this paper
• Dapagliflozin Plus Metformin Versus Metformin Alone in Overweight and Obese Patients with Polycystic Ovary Syndrome - An Open-Label, Parallel, Randomized Controlled Trial

  2026cites this paper
• Increased DNA and oxidative damage in PCOS: effect of elevated androgens

  2026cites this paper
• Investigation of serum orexin-A levels in women with polycystic ovary syndrome

  2026cites this paper
• Sex steroids, SHBG and type 2 diabetes in women: what do we really know?

  2026cites this paper
• Retinal and Choroidal Structural and Microvascular Characteristics in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) Studies.

  2026cites this paper
• A Retrospective Study for the Evaluation of Serum Anti-Müllerian Hormone and Its Correlation With Insulin Resistance and Lipid Profile in Polycystic Ovary Syndrome in Adolescents

  2025cites this paper
• Ovarian stimulation by promoting basal follicular growth

  2025cites this paper
• Gut microbiota in diabetic-linked polycystic ovarian syndrome: Mechanisms and therapeutic insights.

  2025cites this paper
• Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients

  2025cites this paper
• Hsa_circ_0020491 promotes polycystic ovary syndrome by interacting with IGF2BP2 through regulation of granular cell autophagy and mitochondrial dysfunction

  2025cites this paper
• a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm

  2025cites this paper
• Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management

  2025cites this paper
• Cabergoline monotherapy in polycystic ovary syndrome patients with elevated prolactin: a viable option?

  2025cites this paper
• Deciphering polycystic ovary syndrome: A brief overview from metabolic drivers to genetic and fetal origins.

  2025cites this paper
• Unraveling the Complexity of Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

  2025cites this paper
• Türkiye’de Yetişen ve Jinekolojik Hastalıklarda Önemi Olan Tıbbi Bitkilerin Değerlendirilmesi

  2025cites this paper
• Triglyceride/High-density Lipoprotein Cholesterol Ratio and Triglyceride–Glucose Index: Potential Cost-effective Markers of Insulin Resistance in Polycystic Ovary Syndrome

  2025cites this paper
• Pharmacotherapeutic Role of Ketohexokinase in Metabolic Disorders and PCOS: A Systematic Review

  2025cites this paper
• Leptin and LH/FSH Ratio as Independent Predictors of Polycystic Ovary Syndrome in Normoglycemic Women: A Case-Control Study

  2025cites this paper
• Metabolische und psychische Folgen des PCO-Syndroms – Ansätze für Beratung und Therapie

  2025cites this paper
• Visceral Adiposity Index (VAI) Levels and Metabolic Risk Across Phenotypes of Polycystic Ovary Syndrome (PCOS)

  2025cites this paper
• Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review.

  2025cites this paper
• Exploring GnRH pulsatility in PCOS and the role of GLP-1 as a targeted therapeutic approach

  2025cites this paper
• Polycystic Ovary Syndrome (PCOS): A Complex Endocrine Disorder

  2025cites this paper
• Blood biochemical landscape and new insights into clinical decision-making for polycystic ovary syndrome in Chinese women: a prospective cohort study

  2025cites this paper
• Maternal Hyperandrogenemia and the Long-Term Neuropsychological, Sex Developmental, and Metabolic Effects on Offspring

  2025cites this paper
• The Role of Mitochondrial Dysfunction and Oxidative Stress in Women’s Reproductive Disorders: Implications for Polycystic Ovary Syndrome and Preeclampsia

  2025cites this paper
• The Burden Beyond Reproduction: Characterizing Comorbid Conditions in PCOS and PCOD

  2025cites this paper
• Integrative Machine Learning and Network Analysis of Skeletal Muscle Transcriptomes Identifies Candidate Pioglitazone-Responsive Biomarkers in Polycystic Ovary Syndrome

  2025cites this paper
• Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies

  2025cites this paper
• Comparative efficacy of pharmacological interventions on metabolic and hormonal outcomes in polycystic ovary syndrome: a Network Meta-Analysis of Randomized controlled trials

  2025cites this paper
• Changing Profile of the PCOS Women: A 15 Year Retrospective Cohort Study

  2025cites this paper
• The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women

  2025cites this paper
• Antiandrogens and insulin sensitizers in PCOS management.

  2025cites this paper
• Gynecologic Evaluation and Diagnosis of Nonclassic Congenital Adrenal Hyperplasia

  2025cites this paper
• Rubia cordifolia Linn.: Isolation, molecular docking and BRAC1/PKD1 gene targeting for polycystic ovary syndrome in rats.

  2025cites this paper
• Trends in Hyperinsulinemia and Insulin Resistance Among Nondiabetic US Adults, NHANES, 1999–2018

  2025cites this paper
• Exploring Female Infertility: A Comprehensive Review of Polycystic Ovary Syndrome (PCOS) and Its Impact on Reproductive Health

  2025cites this paper
• ROLE OF METFORMIN VERSUS MYO-INOSITOL IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)

  2025cites this paper
• Prevalence, clinical patterns, and associated risk factors of polycystic ovarian syndrome among women seeking fertility treatment at Kilimanjaro Christian Medical Centre Hospital, Northern Tanzania

  2025cites this paper
• Research progress on the pathogenesis, clinical impact, and traditional Chinese medicine treatment of polycystic ovary syndrome complicated by insulin resistance

  2025cites this paper
• GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity

  2025cites this paper
• The Efficacy of Guizhi Fuling Capsule or Kuntai Capsule Combined With Diane-35 and Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

  2025cites this paper
• Mini-review on insulin resistance assessment: Advances in surrogate indices and clinical applications

  2025cites this paper
• Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review

  2025cites this paper
• Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial

  2025cites this paper
• Engineering modification of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorates polycystic ovary syndrome by enhancing the ovarian environment and regulating follicular development

  2025cites this paper
• Comorbidity patterns and predictive factors in polycystic ovary syndrome: a cross-sectional study

  2025cites this paper
• The Impact of BMI on PCOS Patients and Transcriptome Profiling and Bioinformatic Analysis of Granulosa Cells in PCOS Patients with High and Low BMI

  2025cites this paper
• Therapeutic efficacy of Rosa damascena Mill. on oxidative stress parameters and cyclooxygenase-2 gene expression in estradiol valerate-induced polycystic ovarian syndrome in Wistar rats

  2025cites this paper
• Dose-response relationship between physical activity and visceral fat mass: a cross-sectional study based on NHANES 2011–2018

  2025cites this paper
• The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome

  2025cites this paper
• Polycystic ovary syndrome and cardiometabolic risk: A perspective on women's heart health

  2025cites this paper
• The Role of DNA Methylation in Insulin Resistance and Metabolic Dysregulation in Polycystic Ovary Syndrome Patients: A Systematic Review

  2025cites this paper
• Comparison of two different anti-mullerian hormone measurement methods and evaluation of anti-mullerian hormone in polycystic ovary syndrome

  2025cites this paper
• Exploring the role of ferroptosis and lipid metabolism in polycystic ovary syndrome: mechanisms and therapeutic strategies

  2025cites this paper
• Relationship of Body Mass Index and Dietary Inflammatory Index With Free Androgen Index and Insulin Resistance in Women With Polycystic Ovary Syndrome.

  2025cites this paper
• Nonobese PCOS Compared to Obese PCOS Have Similar Clinical Presentation, Hormonal Profile, and Insulin Resistance

  2025cites this paper
• CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes

  2025cites this paper
• Pathophysiology and diagnostic criteria of PCOS.

  2025cites this paper
• Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012–2023)

  2025cites this paper
• Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

  2025cites this paper
• How Health Systems World-wide Fail Type 2 Diabetics

  2025cites this paper
• Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review

  2025cites this paper
• Modulation of hormonal, metabolic, inflammatory and oxidative stress biomarkers in women with polycystic ovary syndrome following combined (resistant and endurance) training: a randomized controlled trail

  2025cites this paper
• Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation

  2025cites this paper
• Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome

  2025cites this paper
• Correlation between adiponectin levels, insulin resistance, and oxidative stress in polycystic ovary syndrome patients: implications for novel therapeutic approaches

  2025cites this paper
• Anti-androgenic compound Embelin ameliorates polycystic ovary syndrome by reversing the ovarian dysfunction and associated metabolic irregularities in 5α-DHT-induced PCOS rats.

  2025cites this paper
• Prevalence and Predictors of Metabolic Syndrome in Women with Polycystic Ovarian Syndrome: A Cross-Sectional Study

  2025cites this paper
• Rhein attenuates oxidative stress-induced injury in human ovarian granulosa cells by inhibiting the NF-κB-TNF-α/IL-6/PTGS2 inflammatory axis.

  2025cites this paper
• THE IMPACT OF POLYCYSTIC OVARY SYNDROME (PCOS) ON THE MENTAL HEALTH OF PATIENTS – A CROSS-SECTIONAL STUDY WITH EXTENDED CLINICAL AND PUBLIC HEALTH IMPLICATIONS

  2025cites this paper
• Elevated IGFBP7 expression in follicular granulosa cells promotes PCOS pathogenesis.

  2025cites this paper
• Adiponectin Receptor Agonist AdipoRon Ameliorates the Metabolic Complications in a Hyperandrogenic Rat Model of PCOS

  2025cites this paper
• Molecular and Functional Insights into Thyrostimulin and Its Subunits-GPA2/GPB5

  2025cites this paper
• Inositol With Metformin Versus Metformin Monotherapy in Polycystic Ovary Syndrome: A Meta‐Analysis of Randomised Controlled Trials

  2025cites this paper
• Obesity is associated with SHBG levels rather than blood lipid profiles in PCOS patients with insulin resistance

  2024cites this paper
• Polycystic Ovary Syndrome in Adolescents.

  2024cites this paper
• Trends in hyperinsulinemia and insulin resistance among nondiabetic US adults, NHANES, 1999–2018

  2024cites this paper
• Associations of nutritional status and dietary habits with the development of female infertility. A case–control study

  2024cites this paper
• Protocol for a randomized comparative effectiveness trial comparing a very low-carbohydrate diet to DASH diet for polycystic ovary syndrome: the SUPER (Supporting Understanding of PCOS Education and Research) trial

  2024cites this paper
• Impaired glucose tolerance and insulin resistance in a prenatally‐androgenized rat model of polycystic ovary syndrome in later life

  2024influential citation
• Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease

  2024cites this paper
• Insulin resistance and insulin secretory defect among Bangalee PCOS women: a case-control study

  2024cites this paper
• SFRP4 contributes to insulin resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis.

  2024cites this paper
• Exploring the Link Between Metabolic Syndrome and Cellulite

  2024cites this paper
• Hiperandrogenismo en la adolescente

  2024cites this paper
• A Novel “Endocrine Hormone”: The Diverse Role of Extracellular Vesicles in Multiorgan Insulin Resistance

  2024cites this paper
• New update of the international PCOS guideline—Focus on evidence‐based medicine in the treatment of PCOS

  2024cites this paper
• Obesity is associated with hyperandrogenemia in a nationally-representative sample of U.S. girls aged 6-18 years.

  2024cites this paper
• Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome

  2024cites this paper
• Six-month randomized, placebo controlled trial of synbiotic supplementation in women with polycystic ovary syndrome undergoing lifestyle modifications

  2024cites this paper
• Regulation of ovarian function in obese women: pathogenetic mechanisms

  2024cites this paper
• Comparison of metformin, myoinositol and metformin-myoinositol combined treatments for polycystic ovary syndrome

  2024cites this paper